Alzheimer's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
This trial is open to four different groups of people. You may qualify if you fall into one of these categories:
Group 1 – Cognitively Healthy Individuals:
- Your memory and thinking abilities score within the normal range on standard cognitive tests.
- You can speak and understand Thai fluently without needing a translator.
Group 2 – Mild Cognitive Impairment:
- Your memory or thinking abilities score below the normal range on standard cognitive tests.
- A doctor has determined that your difficulties do not yet reach the level of dementia.
- You can speak and understand Thai fluently without needing a translator.
Group 3 – Late-Onset Dementia:
- Your memory or thinking abilities score below the normal range on standard cognitive tests.
- A doctor has formally diagnosed you with dementia (including Alzheimer's disease or other causes).
- Your dementia symptoms first appeared after the age of 65.
- You can speak and understand Thai fluently without needing a translator.
Group 4 – Early-Onset Dementia:
- Your memory or thinking abilities score below the normal range on standard cognitive tests.
- A doctor has formally diagnosed you with dementia (including Alzheimer's disease or other causes).
- Your dementia symptoms first appeared before the age of 65.
- You can speak and understand Thai fluently without needing a translator.
Who may not be able to join:
- You have a significant neurological condition or a psychiatric illness that is not well controlled by treatment.
- You have a serious, unstable physical health condition or an organ (such as the heart, liver, or kidneys) that is failing in a way that could affect your ability to take part in the study.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Thiravat Hemachudha, M.D., Chulalongkorn University
Phone: +66 (0)2 2564000
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Progression to dementia; Changes in Sum of Boxes of the Clinical Dementia Rating Scale
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.